Dan Puckett, Chief Financial Officer at Shockwave Medical, Inc. (SWAV), sold 200 shares at $173.88 ($35K) on 2023-12-08, disclosed to the SEC on 2023-12-11.
Scheduled sale ($35k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SWAV | SELL | 2023-05-12 | $1.2M | — | Filing → |
| SWAV | SELL | 2023-04-19 | $530K | — | Filing → |
| SWAV | SELL | 2023-03-22 | $221K | — | Filing → |